TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	79.15	179.89	92.93	102.3	298.89
Short-Term Investments	62.82	131.11	124.58	59.37	15.88
Cash & Short-Term Investments	141.97	311	217.51	161.68	314.76
Cash Growth	-54.35%	42.98%	34.53%	-48.63%	-48.01%
Accounts Receivable	305.63	129.19	51.09	-	1.39
Inventory	125.59	110.46	39.82	-	-
Other Current Assets	57.58	15.72	9.52	6.6	14.81
Total Current Assets	630.76	566.36	317.94	168.27	330.97
Net Property, Plant & Equipment	6.28	7.15	8.05	10.82	11.07
Goodwill	-	-	-	0.8	0.8
Long-Term Investments	59.14	0.81	-	12.4	35.53
Other Long-Term Assets	367.08	3.37	3.59	1.27	1.26
Total Assets	1,063	577.69	329.59	193.57	379.63
Accounts Payable	107.51	58.3	38.47	42.02	51.29
Accrued Expenses	21.85	15.19	12.17	8.43	10.17
Current Portion of Long-Term Debt	-	-	-	-	0.98
Current Portion of Leases	1.04	1.16	1.45	1.58	1.44
Unearned Revenue	21.23	11.41	0.15	-	-
Other Current Liabilities	2.12	4.63	1.48	1.17	1.51
Total Current Liabilities	153.76	90.68	53.72	53.2	65.38
Long-Term Debt	245.65	244.43	100.12	71.14	66.79
Long-Term Leases	7.02	8.13	9.23	10.34	9.85
Other Long-Term Liabilities	8.81	12.09	6.02	0.31	0.46
Total Long-Term Liabilities	261.47	264.65	115.37	81.78	77.09
Total Liabilities	415.23	355.33	169.09	134.99	142.48
Common Stock	0.16	0.16	0.15	0.15	0.14
Treasury Stock	-100.23	-8.99	-0.23	-0.23	-0.23
Additional Paid-in Capital	1,830	1,760	1,713	1,586	1,566
Retained Earnings	-1,082	-1,529	-1,553	-1,527	-1,329
Shareholders' Equity	648.02	222.36	160.5	58.59	237.15
Total Liabilities & Equity	1,063	577.69	329.59	193.57	379.63
Total Debt	253.71	253.72	110.8	83.06	79.05
Net Cash (Debt)	-111.74	57.28	106.71	78.62	235.72
Net Cash Growth	-	-46.32%	35.74%	-66.65%	-58.17%
Net Cash Per Share	-0.69	0.36	0.72	0.58	1.78
Book Value	648.02	222.36	160.5	58.59	237.15
Book Value Per Share	4.01	1.39	1.08	0.43	1.79
Tangible Book Value	648.02	222.36	160.5	57.79	236.35
Tangible Book Value Per Share	4.01	1.39	1.08	0.43	1.79

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q